Clicky

Fagron NV(4A5)

Description: Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.


Keywords: Pharmacy Medication Hair Care Products Symbols Compounding Pharmacist Alopecia Fagron Academy Pharmaceutical Compounding Compound Pharmaceutical Treatment Hypopigmentation Disorders Imuno Tf Complex Personalized Pharmaceutical Care Scars Ang Keloids

Home Page: www.fagron.com

Venecoweg 20A
Nazareth, 9810
Belgium
Phone: 32 8 001 28 80


Officers

Name Title
Mr. Rafael Padilla CEO & Executive Director
Ms. Karin de Jong CFO & Executive Director
Ms. Vera Bakker Chief Operating Officer
Karen Berg Global Investor Relations Manager
Mr. Johan Verlinden Head of Legal, Mergers & Acquisitions

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 14.4928
Trailing PE: 16.8037
Price-to-Book MRQ: 2.7684
Price-to-Sales TTM: 1.6045
IPO Date:
Fiscal Year End: December
Full Time Employees: 3647
Back to stocks